Evidence of safety for pretomanid and male reproductive health.

Burke, A; Alffenaar, J; Denholm, J

Burke, A; Alffenaar, J; Denholm, J.

Afiliação

Burke A; The Prince Charles Hospital, Brisbane, QLD, Australia, Faculty of Medicine, The University of Queensland School of Medicine, Herston, QLD, Australia.
Alffenaar J; Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia.
Denholm J; Victorian Tuberculosis Program, Melbourne Health, Melbourne, VIC, Australia, Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia.

Int J Tuberc Lung Dis ; 26(6): 473-474, 2022 06 01.

Article em En | MEDLINE | ID: mdl-35650707

Assuntos

Nitroimidazóis; Saúde Reprodutiva; Antituberculosos/uso terapêutico; Humanos; Masculino

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_neglected_diseases / 3_tuberculosis Assunto principal: Saúde Reprodutiva / Nitroimidazóis Limite: Humans / Male Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google